Colorectal cancer in young patients often advanced at diagnosis, study finds
A review of 84 patients aged 21 or younger found most already had Stage III or IV colorectal cancer at diagnosis, with many dying from the disease.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
FDA Should Reject Grail's Multicancer Blood Test, Physician Argues
A cancer screening researcher contends that Grail's test failed its randomized trial and that approval would trigger mandated Medicare coverage of an unproven screen.
Doctor: AI Charting Tools Can Inflate Hospital Bills Without Better Care
A resident physician argues that AI-assisted documentation can drive up hospital costs through 'bump codes,' but says the fix is better tools and clinician judgment, not abandoning AI.
Pulse oximeters at Johns Hopkins shifted from over- to underestimating blood oxygen
A five-year retrospective study finds pulse oximeter inaccuracy is inconsistent, complicating clinical adjustments.
Longevity clinics at nonprofit hospitals draw criticism over evidence
Prestigious health systems are selling $5,500 longevity assessments, but critics question the evidence and nonprofit fit.
GE HealthCare to Acquire Radiopharmaceutical CMO Sofie for $945M
The cash deal adds U.S. manufacturing and distribution capacity for short-lived PET tracers and gives GE HealthCare rights to a pan-cancer imaging agent.
Flu Shot Timing: West Coast Now, Rest of U.S. Within Weeks
CDC data shows minimal flu activity nationally, but regional upticks mean vaccination timing should vary by location.
Maternity Care Gaps: Hidden Risks and Costs Health Plans Overlook
A new ProgenyHealth report highlights how traditional maternity and NICU care management misses key risks, driving avoidable costs for commercial and Medicaid plans.
ArriVent's lung cancer drug fails key trial, wiping out half its value
A late-stage failure for ArriVent's furmonertinib removes a potential challenger in the competitive EGFR exon 20 lung cancer market.
Institutional Betrayal Compounds Trauma for Sexual Assault Survivors
A physician argues that healthcare and university systems fail survivors through incomplete care and silencing, worsening long-term health outcomes.
Rethinking Clinical Dashboards: From Reports to Actionable Nudges
A practicing physician argues that current quality dashboards overwhelm clinicians with untimely data and should be rebuilt as actionable tools.
Vaxcyte's 31-strain pneumococcal vaccine succeeds in Phase 3 trial
Vaxcyte's VAX-31 matched or beat Pfizer and Merck shots on most strains, moving the biotech closer to competing in the $8 billion pneumococcal vaccine market.
Could an AI like Claude ever win a Nobel Prize in medicine?
A former Harvard Medical School dean argues the Nobel committee and scientific community must rethink how credit is assigned as AI becomes a driver of discovery.
Hospital and Drug Prices, Not Overuse, Drive Premium Spiral, STAT Finds
A STAT investigation finds that opaque, high prices across health care—not how often patients seek care—are the main driver of rising insurance premiums.
AI-driven drug pipelines push biopharma facilities toward speed and flexibility
A construction-industry perspective says AI is compressing drug development timelines, forcing manufacturing facilities to be built faster, more flexibly, and with digital infrastructure from the start.
Stem cell industry hopes FDA will treat it like peptides
Stem cell entrepreneurs believe the FDA's recent openness to peptides could pave the way for regulation of unapproved stem cell therapies.
mRNA Cancer Vaccine Slows Melanoma, but Big Questions Remain
A late-stage mRNA vaccine reduced melanoma recurrence, yet researchers still face uncertainty about which cancers the approach can tackle.
64% of eligible advanced NSCLC patients miss targeted therapy, Diaceutics says
A Diaceutics-sponsored analysis argues that broken diagnostic workflows, not science, are the main barrier to targeted therapy uptake.